BlackRock Investment Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $2.85M | Buy |
85,043
+12,417
| +17% | +$416K | ﹤0.01% | 1972 |
|
|
2016
Q3 | $1.93M | Buy |
72,626
+96
| +0.1% | +$2.56K | ﹤0.01% | 2180 |
|
|
2016
Q2 | $1.6M | Buy |
72,530
+8,836
| +14% | +$195K | ﹤0.01% | 2288 |
|
|
2016
Q1 | $1.87M | Buy |
63,694
+1,209
| +2% | +$35.5K | ﹤0.01% | 2049 |
|
|
2015
Q4 | $2.06M | Buy |
62,485
+171
| +0.3% | +$5.65K | ﹤0.01% | 2064 |
|
|
2015
Q3 | $2.25M | Buy |
62,314
+5,505
| +10% | +$199K | ﹤0.01% | 1991 |
|
|
2015
Q2 | $2.56M | Buy |
56,809
+26,467
| +87% | +$1.19M | ﹤0.01% | 2030 |
|
|
2015
Q1 | $929K | Buy |
30,342
+363
| +1% | +$11.1K | ﹤0.01% | 2565 |
|
|
2014
Q4 | $1.52M | Sell |
29,979
-78
| -0.3% | -$3.97K | ﹤0.01% | 2241 |
|
|
2014
Q3 | $1.19M | Buy |
30,057
+143
| +0.5% | +$5.66K | ﹤0.01% | 2392 |
|
|
2014
Q2 | $1.29M | Buy |
29,914
+19,588
| +190% | +$843K | ﹤0.01% | 2407 |
|
|
2014
Q1 | $413K | Buy |
10,326
+208
| +2% | +$8.32K | ﹤0.01% | 3029 |
|
|
2013
Q4 | $276K | Sell |
10,118
-5
| -0% | -$136 | ﹤0.01% | 3148 |
|
|
2013
Q3 | $232K | Buy |
10,123
+1,035
| +11% | +$23.7K | ﹤0.01% | 3147 |
|
|
2013
Q2 | $161K | Buy |
+9,088
| New | +$161K | ﹤0.01% | 3185 |
|